These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

691 related items for PubMed ID: 11974560

  • 1. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S.
    Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
    [Abstract] [Full Text] [Related]

  • 2. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA, Wang ST, Chen CH, Pai MC, Wu MH, Huang KE.
    Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
    [Abstract] [Full Text] [Related]

  • 3. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS, Carlström K, Jonsson B, Jonasson AF.
    Maturitas; 2006 Jan 10; 53(1):89-96. PubMed ID: 15964160
    [Abstract] [Full Text] [Related]

  • 4. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
    Bots ML, Evans GW, Riley W, McBride KH, Paskett ED, Helmond FA, Grobbee DE, OPAL Investigators.
    Eur Heart J; 2006 Mar 10; 27(6):746-55. PubMed ID: 16415304
    [Abstract] [Full Text] [Related]

  • 5. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
    Pan HA, Wang ST, Pai MC, Chen CH, Wu MH, Huang KE.
    J Reprod Med; 2003 May 10; 48(5):375-80. PubMed ID: 12815913
    [Abstract] [Full Text] [Related]

  • 6. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV, Christodoulakos GE, Panoulis CP, Rizos DA, Dendrinos SG, Liakakos T, Augoulea AD, Creatsas GC.
    Maturitas; 2004 Jun 15; 48(2):107-13. PubMed ID: 15172084
    [Abstract] [Full Text] [Related]

  • 7. An open-label study of subdermal implants of estradiol-only versus subdermal implants of estradiol plus nomegestrol acetate: effects on symptom control, lipid profile and tolerability.
    Barbosa IC, Coutinho EM, Oladapo L, Noronha CF, Mota RL, Lopes AC, Lopes RC.
    Gynecol Endocrinol; 2009 Apr 15; 25(4):269-75. PubMed ID: 19408176
    [Abstract] [Full Text] [Related]

  • 8. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA, Liu JH, Speroff L, Shumel BS, Symons JP.
    Am J Obstet Gynecol; 2003 Jan 15; 188(1):92-9. PubMed ID: 12548201
    [Abstract] [Full Text] [Related]

  • 9. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.
    Climacteric; 2007 Oct 15; 10(5):400-7. PubMed ID: 17852143
    [Abstract] [Full Text] [Related]

  • 10. A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
    Skouby SO, Sidelmann JJ, Nilas L, Jespersen J.
    Hum Reprod; 2007 Apr 15; 22(4):1186-91. PubMed ID: 17204528
    [Abstract] [Full Text] [Related]

  • 11. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA, Osmanağaoğlu S, Osmanağaoğlu T, Okumuş B, Bozkaya H.
    Fertil Steril; 2005 Aug 15; 84(2):384-93. PubMed ID: 16084879
    [Abstract] [Full Text] [Related]

  • 12. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S, Moghasemi M, Faghihzadeh S.
    Climacteric; 2010 Apr 15; 13(2):147-56. PubMed ID: 19731119
    [Abstract] [Full Text] [Related]

  • 13. The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
    Skouby SO, Sidelmann JJ, Nilas L, Gram J, Jespersen J.
    Climacteric; 2008 Apr 15; 11(6):489-97. PubMed ID: 18991076
    [Abstract] [Full Text] [Related]

  • 14. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF, Pickar JH, Bottiglioni F.
    Obstet Gynecol; 1994 May 15; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [Abstract] [Full Text] [Related]

  • 15. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D, Yeşildaglar N, Erkaya S.
    Gynecol Endocrinol; 2005 Apr 15; 20(4):209-12. PubMed ID: 16019363
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
    Ziaei S, Moaya M, Faghihzadeh S.
    Climacteric; 2010 Jun 15; 13(3):249-53. PubMed ID: 19848555
    [Abstract] [Full Text] [Related]

  • 17. Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women.
    Valdivia I, Campodónico I, Tapia A, Capetillo M, Espinoza A, Lavín P.
    Fertil Steril; 2004 Mar 15; 81(3):617-23. PubMed ID: 15037411
    [Abstract] [Full Text] [Related]

  • 18. Psychological effects of tibolone and sequential estrogen-progestogen therapy in perimenopausal women.
    Inan I, Kelekci S, Yilmaz B.
    Gynecol Endocrinol; 2005 Feb 15; 20(2):64-7. PubMed ID: 15823823
    [Abstract] [Full Text] [Related]

  • 19. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P.
    Arch Gynecol Obstet; 2006 Aug 15; 274(5):289-96. PubMed ID: 16810536
    [Abstract] [Full Text] [Related]

  • 20. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
    Diaby V, Perreault S, Lachaine J.
    Maturitas; 2007 Oct 20; 58(2):138-49. PubMed ID: 17870259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.